首页> 美国卫生研究院文献>Epidemiology and Infection >Protective efficacy of RIT 4025 a live attenuated influenza vaccine strain and evaluation of heterotypic immunity to influenza A viruses in ferrets.
【2h】

Protective efficacy of RIT 4025 a live attenuated influenza vaccine strain and evaluation of heterotypic immunity to influenza A viruses in ferrets.

机译:减毒活流感疫苗株RIT 4025的保护功效以及对雪貂对A型流感病毒的异型免疫力的评估。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Ferrets immunized with an H3N2 recombinant of A/PR/8/34 and A/Scotland/840/74 (RIT 4025 vaccine strain) were almost completely protected against a challenge with the homologous strain A/Scotland/840/74. The protection was lower but highly significant when the challenge was performed with the heterologous A/Victoria/3/75 wild strain. The protection afforded by the vaccine strain was measured by three indicators: absence of temperature rise, absence or reduction of virus shedding and absence or reduction of nasal protein increase when compared with uninoculated controls. Heterotypic immunity in this animal model was not significant when these three indicators were measured after a challenge inoculation performed 5 weeks after immunization.
机译:用A / PR / 8/34和A / Scotland / 840/74(RIT 4025疫苗株)的H3N2重组体免疫的雪貂几乎被完全保护免受同源株A / Scotland / 840/74的攻击。当用异源A / Victoria / 3/75野生株进行攻击时,保护作用较低,但高度重要。与未接种的对照相比,疫苗株提供的保护通过三个指标来衡量:温度没有升高,病毒脱落没有或减少,鼻蛋白增加或没有减少。当在免疫后5周进行挑战接种后,对这三个指标进行测量时,该动物模型中的异型免疫力并不显着。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号